MED — MEDIFAST INC

NYSE · Consumer Staples · Food Products · CIK 910329 ·
Last close
$9.68
Market Cap
$107.63M
52W High
$13.43
52W Low
$9.39
ADV30
255,513
Next earnings
2026-08-03
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 76,044,000 51,756,000 -3,295,000 -2,122,000 252,046,000 71,529,000 54,365,000
Dec 2025 75,096,000 52,140,000 -7,803,000 -18,119,000 247,973,000 89,303,000 49,053,000
Sep 2025 89,409,000 62,159,000 -4,081,000 -2,261,000 268,209,000 99,526,000 53,503,000
Jun 2025 105,555,000 76,644,000 -1,066,000 2,480,000 269,333,000 101,694,000 53,328,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,717,000
Investing CF
$-23,007,000
Financing CF
$-902,000
CapEx
$-5,188,000
Dividends Paid
$-88,000
Buybacks
$-814,000
EPS Diluted TTM
$-1.83
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$156,149,000
Inventory
$21,403,000
Receivables
ST Investments
$97,417,000
EBIT TTM
$-16,245,000
Pretax Income TTM
$-8,105,000
Interest Exp TTM
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$346,104,000
EBITDA
$-3,985,000
Free Cash Flow
$4,411,250
Enterprise Value
$-53,594,848
Total Cash
$168,946,000
Total Debt
$16,101,000
Shares Out
11,119,115
Trailing EPS
$-1.86
Book Value
$19.28
ROE
-9.8%
ROA
-4.3%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 385,788,000 -14,213,000 -18,672,000 247,973,000 49,053,000 6,863,000
Dec 2024 602,463,000 2,878,000 2,091,000 284,213,000 74,104,000 24,476,000
Dec 2023 1,072,054,000 126,402,000 99,415,000 309,908,000 108,427,000 147,657,000
Dec 2022 1,598,577,000 184,806,000 143,568,000 316,213,000 161,169,000 194,570,000

TTM Snapshot

Revenues TTM
$168,558,000
NetIncome TTM
$-8,154,000
OpCashFlow TTM
$0
Assets (Latest)
$284,213,000
Forward EPS
$-0.60

Max Pain — expiry 2026-09-18

max pain strike: $7.50 · spot: $9.68 · call oi: 11,793 · put oi: 1,325
Expected Move to 2026-09-18: ±$1.25 (12.91%) — implied range $8.43$10.93 · ATM straddle on $10.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ZVIA Zevia PBC $107.66M $1.50
BUDA BUDA JUICE, INC. $113.23M $9.01
TAP-A MOLSON COORS BEVERAGE CO $101.27M $39.51
BRCC BRC Inc. $126.36M $1.08
GWLL GOLDENWELL BIOTECH, INC. $89.10M $0.90

News headlines (Yahoo Finance, 1h cache)

Vita Coco Q2 Earnings Beat on Strong Volume, 2026 Guidance Higher
2026-07-24 15:20 · Yahoo
How Is Post Holdings Rebuilding Its Pet Food Portfolio for Growth?
2026-07-22 16:21 · Yahoo
Can Simpler Pricing Improve Kroger's Customer Retention?
2026-07-21 17:13 · Yahoo
Portfolio Diversification and Premiumization Fuel Molson Coors' Outlook
2026-07-21 15:45 · Yahoo
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2026
2026-07-20 20:05 · Yahoo
Will Medifast's Trilivy Launch Unlock a New Growth Chapter?
2026-07-20 14:27 · Yahoo
Medifast® Enters a New Era: Introducing Trilivy™, a Science-Backed Metabolic Health System
2026-07-17 12:30 · Yahoo
3 Unpopular Stocks That Concern Us
2026-07-16 11:37 · Yahoo
Archer Daniels Jumps 52% in a Year: Key Factors Behind the Surge
2026-07-15 14:32 · Yahoo
Brand Strength and Innovation Support Brown-Forman's Expansion
2026-07-14 18:32 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.